Fedha

Hisa unazofuatilia
EW:NYSE
Edwards Lifesciences Corp
US$ 106.98
+1.03%
(+1.09) Siku 1
13 Nov, 09:59:08 GMT -5  ·   USD
Alama zote
AlamaBeiTofautiTofauti ya asilimia
Inatayarisha maarifa maarufu ya EW...
Fungua
US$ 106.10
Juu
US$ 107.09
Chini
US$ 106.01
Mtaji wa soko
61.51B
Wastani wa kiasi cha mauzo
4.51M
Kiasi cha mauzo ya hisa
elfu 124.21
Uwiano wa bei ya hisa na mapato kwa kila hisa
60.65
Juu kwa wiki 52
US$ 107.09
Chini kwa wiki 52
US$ 74.66
EPS
US$ 1.76
Beta
0.85
Hisa za wawekezaji
575.00M
Idadi ya wafanyakazi
elfu 16
Fungua
US$ 106.10
Juu
US$ 107.09
Chini
US$ 106.01
Mtaji wa soko
61.51B
Wastani wa kiasi cha mauzo
4.51M
Kiasi cha mauzo ya hisa
elfu 124.21
Uwiano wa bei ya hisa na mapato kwa kila hisa
60.65
Juu kwa wiki 52
US$ 107.09
Chini kwa wiki 52
US$ 74.66
EPS
US$ 1.76
Beta
0.85
Hisa za wawekezaji
575.00M
Idadi ya wafanyakazi
elfu 16
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
Wasifu
Edwards Lifesciences Corporation is an American medical technology company headquartered in Irvine, California, specializing in tissue heart valves and transcatheter technologies for the treatment of structural heart disease. The company has manufacturing facilities at the Irvine headquarters, as well as in Draper, Utah; Costa Rica; Singapore; and Limerick, Ireland. The company is also constructing a manufacturing plant in Moncada, near Valencia, Spain, with a €150 million investment. Production is scheduled to begin in 2027. Wikipedia
Kuhusu Edwards Lifesciences Corp
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazielfu 16
Lilianzishwa1958
Makao makuuIrvine, California, Marekani
SektaHealth Care
Sekta-
Tovutiedwards.com
Ukadiriaji wa mchanganuzi
Kulingana na wachanganuzi 23 waliotoa ukadiriaji wa hisa kwa EW katika miezi 3 iliyopita
Imenunuliwa sana
Nunua
20
Shikilia
3
Uza
0
Utabiri wa miezi 12
Kulingana na wachanganuzi 23 wa Wall Street wanaotoa makadirio ya bei ya miezi 12 ya EW katika miezi 3 iliyopita.
Juu kabisa
Ya sasa US$ 106.98
US$ 125.00 (+16.84%)
Wastani
US$ 114.50 (+7.03%)
Chini kabisa
US$ 97.00 (-9.33%)
Mchanganuzi
Unaopendekezwa
Kitendo
Bei lengwa
Unaokadiriwa
Tarehe
Travis Steed
Bank of America Securities
Buy
Maintained
-
-
11/09/2026
Jaret Seiberg
TD Cowen
Buy
Reiterated
US$ 121.00
+13.1%
11/11/2026
Unknown Analyst
Oppenheimer
Hold
Maintained
-
-
11/05/2026
Mike Kratky
Leerink Partners
Buy
Reiterated
US$ 112.00
+4.7%
11/05/2026
Anthony Petrone
Mizuho Securities
Buy
Maintained
US$ 120.00
+12.2%
11/05/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
US$ 112.00
+4.7%
11/05/2026
David Rescott
Robert W. Baird
Buy
Upgraded
US$ 116.00
+8.4%
11/05/2026
David Roman
Goldman Sachs
Buy
Maintained
US$ 115.00
+7.5%
11/05/2026
Kendall Au
RBC Capital
Buy
Reiterated
US$ 115.00
+7.5%
11/05/2026
Shagun Singh Chadha
RBC Capital
Buy
Reiterated
US$ 115.00
+7.5%
11/05/2026
Rick Wise
Stifel Nicolaus
Buy
Maintained
US$ 120.00
+12.2%
11/05/2026
Adam Maeder
Piper Sandler
Buy
Reiterated
US$ 115.00
+7.5%
11/05/2026
Robbie Marcus
J.P. Morgan
Buy
Maintained
US$ 120.00
+12.2%
11/05/2026
Patrick Wood
UBS
Buy
Reiterated
US$ 118.00
+10.3%
11/05/2026
Lee Hambright
Bernstein
Hold
Maintained
US$ 106.00
-0.9%
11/05/2026
Larry Biegelsen
Wells Fargo
Buy
Reiterated
US$ 113.00
+5.6%
11/05/2026
Joanne Wuensch
Citi
Buy
Reiterated
US$ 117.00
+9.4%
11/05/2026
Nico Chen
DBS
Buy
Maintained
US$ 125.00
+16.8%
11/05/2026
William Plovanic
Canaccord Genuity
Hold
Maintained
US$ 97.00
-9.3%
11/05/2026
Christopher Pasquale
Barclays
Buy
Maintained
US$ 120.00
+12.2%
11/05/2026
Richard Newitter
Truist Financial
Buy
Upgraded
US$ 113.00
+5.6%
11/03/2026
Chris Krueger CFA
TD Cowen
Buy
Reiterated
US$ 117.00
+9.4%
11/05/2026
Josh Jennings
TD Cowen
Buy
Reiterated
US$ 117.00
+9.4%
11/03/2026
Marie Thibault
BTIG
Buy
Reiterated
US$ 110.00
+2.8%
10/09/2026
Matt Miksic
Barclays
Buy
Maintained
US$ 110.00
+2.8%
10/07/2026
Tycho Peterson
Jefferies
Buy
Initiated
US$ 110.00
+2.8%
10/07/2026
Matthew Taylor
Jefferies
Buy
Maintained
US$ 105.00
-1.9%
09/11/2026
Brandon Vazquez
William Blair
Buy
Maintained
-
-
09/10/2026
Suraj Kalia
Oppenheimer
Hold
Maintained
-
-
07/24/2026
Krish Sankar
TD Cowen
Buy
Reiterated
US$ 104.00
-2.8%
06/02/2026
David Toung
Argus Research
Buy
Maintained
-
-
05/21/2026
Michael Polark
Wolfe Research
Buy
Upgraded
US$ 92.00
-14%
04/01/2026
Danielle Antalffy
UBS
Hold
Maintained
US$ 90.00
-15.9%
02/12/2026
Ripoti ya mwisho
5 Nov 2026
Kipindi cha Kifedha
Robo3 2026
US$ 0.80 / US$ 0.74
+8.62%umepitiliza
Mapato dhidi ya makadirio (USD)
1.72B / 1.68B
+2.31%umepitiliza
Mkutano pepe wa kujadili mapato ya robo ya Robo ya 3 ya mwaka wa fedha wa 2026
Inasubiri mkutano pepe wa kujadili mapato
Kwa muhtasari
Maarifa kutoka kwenye ripoti na habari za hivi punde
Ripoti za awaliThamani zote katika USD
Loading Previous Earnings...
Mapato
Mapato halisi
Thamani zote katika USD
Des 2025
Mac 2026
Jun 2026
Sep 2026
Mapato
1.57B
1.65B
1.74B
1.72B
Gharama ya bidhaa zilizouzwa
343.00M
362.60M
392.40M
369.20M
Gharama ya mapato
343.00M
362.60M
392.40M
369.20M
Gharama za utafiti na maendeleo
267.70M
263.30M
278.90M
281.40M
Jumla ya gharama za utafiti na maendeleo
-
-
-
-
Gharama za uuzaji, za jumla na za usimamizi
601.20M
522.20M
561.20M
560.90M
Gharama ya uendeshaji
854.60M
771.30M
829.10M
829.00M
Jumla ya gharama za uendeshaji
1.20B
1.13B
1.22B
1.20B
Mapato ya uendeshaji
372.00M
514.70M
519.50M
517.30M
Mapato mengine yasiyo ya uendeshaji
2.30M
69.90M
-25.00M
25.90M
EBT ikijumuisha vipengee visivyo vya kawaida
90.40M
459.00M
519.80M
363.20M
EBT bila kujumuisha vipengee visivyo vya kawaida
464.00M
603.60M
511.10M
560.80M
Gharama ya kodi ya mapato
26.20M
78.30M
278.40M
61.80M
Kiwango cha kodi kinachotumika
28.98%
17.06%
53.56%
17.02%
Gharama nyingine za uendeshaji
-14.30M
-14.20M
-11.00M
-13.30M
Mapato halisi
91.20M
380.70M
241.90M
307.50M
Kiwango cha faida halisi
5.81%
23.09%
13.89%
17.92%
Mapato kwa kila hisa
0.58
0.78
0.78
0.80
Mapato ya riba na uwekezaji
114.20M
17.40M
15.00M
15.90M
Gharama ya riba
-20.40M
-
-
-
Jumla ya gharama halisi za riba
93.80M
17.40M
15.00M
15.90M
Gharama za kushuka kwa thamani na za kulipa deni
-
-
-
-
Mapato ya kampuni kabla ya riba, kodi, kushuka thamani na kulipa madeni
414.70M
555.60M
562.20M
562.20M
Faida au hasara kutokana na uuzaji wa vipengee
-33.90M
-
-
-
Miamala ya wajuzi wa mambo
Data ya miamala ya watu wenye hisa hutolewa kwenye vyanzo vya washirika wengine. Pata maelezo zaidi
Mjuzi wa mambo
Nafasi
Aina
Tarehe
Hisa
Kiasi
Ukurasa wa 1
Matukio yajayo
Maudhui yaliyotayarishwa kwa AI yanaweza kuwa na makosa. Pata maelezo zaidi
UsaidiziTuma maoniFaraghaSheria na MashartiKanusho
Programu za Google